Multiple Sclerosis
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
Researchers have been making strides studying the COVID-19 virus in relation to other or secondary conditions since shortly after the epidemic started. Current efforts point to potential compromising impact of the virus on a person's immune system and its ability to ward off disease onset. Multiple Sclerosis (MS) is one such condition being looked at from this lens, not unlike research seeking to better understand the relationship between infection from Epstein Barr Virus (EBV) and the later development of MS.
In the US, 25,000 people are newly diagnosed with MS every year. It is estimated that today, roughly one million Americans are living with the condition. Diagnosis often happens in one’s 30s, largely considered the prime of life. Globally, over two million people are affected by MS, making it the most common long-term and gradually worsening neurological disease among young adults.
MS is a chronic, progressive disease of the central nervous system. The condition stems from damaged myelin, which is the insulating sheath surrounding nerve fibers in the brain and spinal cord. This damage is caused by an individual’s own immune system. When this happens, the flow of electrical impulses in the brain and spinal cord is are disrupted, causing a wide range of effects. The most common MS symptoms include mobility and vision issues, fatigue, and muscle spasms. Symptoms may be permanent, or they may come and go. While MS is an unpredictable disease, as it progresses, it can become seriously disabling, and in extreme cases, life-threatening.
MS is classified in three ways:
Relapsing-remitting MS (RRMS): the most common form of MS (more than 80% of cases). RRMS involves temporary attacks called relapses. Relapses happen when new symptoms appear, or existing/previous symptoms worsen. Relapses alternate with periods of remission, during which some or all symptoms may disappear.
Primary progressive MS (PPMS): an uncommon form of MS with symptoms that slowly worsen over time, with no relapses or remissions.
Secondary progressive MS (SPMS): a form of MS in which symptoms worsen steadily over time after an initial relapsing-remitting course. Once this happens, there are no further relapses and remissions. Most people with RRMS transition to SPMS in the long term.
MS and COVID-19
Throughout the pandemic, living with a preexisting condition such as MS often heightened individual anxiety of contracting COVID-19 due to uncertainty around if or how the virus could worsen symptoms. As time progressed and scientific understanding of COVID increased, connections between the virus and certain neurological and immunological conditions started to emerge.
For starters, having MS has not appeared to raise overall susceptibility to becoming infected with COVID. However, for MS patients that ended up with COVID, there have been reports of worsening symptomology following infection. One study found that thirty percent of people living with MS were still experiencing symptoms more than four weeks after becoming infected with the COVID virus.
Now researchers are starting to look at any potential connection between COVID and the onset of MS. A 2023 study published in Scientific Reports found that in some cases, COVID-19 appeared to trigger the development of MS. This warrants further research given that there are other findings that demonstrate a link between viral illness and the development of MS. Case in point, the Epstein-Barr virus (EBV) has been associated with the onset of MS: a study reported in Science in January 2022 found that people infected with EBV were 32 times as likely to develop MS as uninfected people.
Advances in MS treatment
Therapy for MS has made great strides since the first disease-modifying therapies (DMTs) were introduced 15+ years ago. Ongoing advances in clinical research are increasing the understanding of MS and effective ways to manage this disease.
In December 2022, the Food and Drug Administration (FDA) approved Ublituximab, a DMT used to treat relapsing forms of RRMS and SPMS. This injectable targets B cells, the cells that damage the nervous system. Clinical trials for Ublituximab resulted in less than one MS relapse over a ten-year time span for patients. Ublituximab is given as a one-hour infusion every six months, which is significantly less time consuming that other MS treatments.
Two years prior in 2020, Ofatumumab was approved by the FDA as an injectable that also targets B cells. This drug decreases MS brain lesions and worsening symptoms. Unlike Ublituximab, it is an injectable taken once a month and reduces relapses by about two-thirds.
In today's research pipeline, there are hundreds of potential therapies undergoing clinical trials to test their safety and whether they work as treatments for MS.
Keep up to date on the latest research
Interested in learning more about multiple sclerosis? Register on ClinicalResearch.com to receive news about MS and related IQVIA clinical trials. Check ClinicalResearch.com often for updates and news on a variety of disease areas and to find out more about some of the latest clinical research trials.
References
MS News Today: Could MS be triggered by COVID-19 molecular mimicry?
National MS Society: COVID-19 Vaccine Guidance
Mayo Clinic: Emerging Treatments for MS
Everyday Health: FDA Approves New Treatment for Relapsing MS
NIH News: Could Epstein Barr Virus Cause MS
Published Date October 25, 2023
Latest News
Obesity
The basics of BMI
BMI, or Body Mass Index, is a standard way to assess weight status - learn why and where it came from
2026-06-18T20:31:00Z
Lupus
Celebrities are using their voice to educate about lupus
<span style="line-height: 115%;">Several musically talented celebrities have brought lupus into the public eye by sharing their personal journeys</span>
2026-06-08T19:26:00Z
Asthma
Tips for dealing with changes to asthma management
<p>Policy changes to medication coverage may increasingly involve inhalers</p>
2026-06-02T12:55:00Z
Menopause
Approaches for dealing with thinning hair
<span style="line-height: 115%;">Hair thinning is one of the most emotionally challenging changes many women experience during menopause</span>
2026-05-22T14:09:00Z
Prostate Cancer
2026 brings new developments in prostate cancer treatment
Several exciting breakthroughs are helping reshape how prostate cancer is detected and treated
2026-05-21T12:32:00Z
Menopause
Supplemental estrogen: pills, patches, and modern options
Understanding the different forms of estrogen, including pills and patches, helps women have more informed conversations with their doctors
2026-05-20T19:17:00Z
Hives
How did urticaria get its name?
Hint: it has something to do with stinging nettles plants...
2026-05-14T14:06:00Z
Melanoma
Melanoma: Separating Myths from Facts
Melanoma can be a serious form of skin cancer - who is at risk and what are smart sun behaviors?
2026-05-05T18:44:00Z
Hypertension
Four foods linked with lower blood pressure
While the foods you eat can raise the risk of developing hypertension, there are also options that can help lower blood pressure.
2026-04-27T14:46:00Z
Healthy Volunteers
Common misconceptions about clinical research
Since many people have never participated in a clinical trial, it can be hard to separate fact from myth - here are some common trial myths, debunked.
2026-04-16T17:04:00Z
Colorectal Cancer
Why is Colorectal Cancer striking at younger ages?
The number of people being diagnosed with colorectal cancer under the age of 50 has greatly increased - what might be the cause of this troubling trend?
2026-03-19T14:02:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2026-03-04T21:19:00Z
Eczema
Atopic Dermatitis: signs and stages
Understanding how atopic dermatitis looks, feels and changes during a flare-up is helpful to patients seeking greater control of their condition
2026-02-26T15:07:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2026-02-18T17:46:00Z
Melanoma
With melanoma is on the rise, research delivers hope
Survival rates are rising thanks to transformative therapies that were unimaginable until recently
2026-02-02T20:39:00Z
Healthy Volunteers
The Protein Boom: a clear trend of 2026 emerges early
<span style="line-height: 107%;">Restaurants, snack brands and consumers all seem to be doubling down on protein</span>
2026-01-20T21:02:00Z
Eczema
Winter and eczema flares: How to reduce and cope
<span style="line-height: 107%;">A few strategies that may help better protect affected skin for a more enjoyable winter </span>
2025-12-15T17:16:00Z
Alzheimer's Disease
Preventing falls at home
Falling can lead to serious health issues in older adults, especially in those with dementia - here are some steps to reduce this risk
2025-11-20T17:56:00Z
Obesity
GLP-1 usage surges in US
Revolutionary medicines appear to usher in new hope, helping people overcome obesity
2025-11-06T20:58:00Z
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis vs. Crohn’s Disease - what's the difference?
IBD comes in two primary forms with similar, unpleasant symptoms, but different management and treatment approaches
2025-10-28T16:55:00Z
Hypertension
Smartwatches getting smarter for better heart health
Smartwatches advance through innovation to identify risk of high blood pressure
2025-09-22T20:46:00Z
Inflammatory Bowel Disease (IBD)
Diet and IBD: eat this, not that
Making lifestyle changes, especially dietary changes, can help limit or lessen flare-ups of IBD
2025-09-19T20:46:00Z
Heart Disease
Genetics and Heart Disease: understanding personal risk
As the scientific community learns more about genetic variants, links to disease onset become clearer
2025-09-17T16:39:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
From NASH to MASH: a meaningful name change
What's in a name? A lot when it comes to engaging patients in care options
2025-09-09T12:19:00Z
Heart Disease
GLP-1: more than a weight loss drug
GLP-1 medicines may be an exciting new frontier for heart disease treatment
2025-08-26T15:35:00Z
Diabetes
Participating in clinical research from your home
A DCT brings cutting-edge research fueled by digital innovation straight into a person's home for utmost convenience
2025-08-05T17:23:00Z
Non-Hodgkin Lymphoma
How dogs are helping advance lymphoma research
Dogs are furry and faithful companions that too can face cancer - learn how some are benefiting from medical research
2025-05-28T17:36:00Z
Melanoma
Advances in Melanoma Treatment
Clinical research is helping bring new, and much-needed, treatments to market
2025-04-15T21:17:00Z
Asthma
New thinking in childhood asthma diagnosis approach
New studies show that over-calculating race risk in asthma diagnostic tools may actually delay diagnosis
2025-03-21T13:51:00Z
Alzheimer's Disease
As America ages, dementia diagnoses poised to double
With humans living longer due to medical breakthroughs, the chance of developing dementia has greatly increased
2025-02-19T13:56:00Z
Multiple Sclerosis (MS)
Is lassitude affecting your attitude?
The extreme fatigue of MS is so unrelenting that it has its own name: lassitude. What can you do to try and improve this feeling?
2025-01-24T18:58:00Z
Asthma
Breathing easy: the work of an asthma inhaler
Inhalers are lifechanging for people living with asthma and other breathing difficulties
2025-01-07T17:33:00Z
Leukemia (AML)
A simple guide to understanding chemo
Chemo is an effective cancer treatment - but what is it exactly and why does it work?
2024-12-09T14:25:00Z
Eczema
Self-care tips during eczema flare-ups
Eczema can be emotionally draining and physically uncomfortable - learn how self-care can change your outlook
2024-11-26T18:46:00Z
Healthy Volunteers
What is a Phase 1 trial?
Phase 1 trials are necessary first steps on the road to clinical breakthroughs and healthy volunteers can help make these a reality.
2024-11-11T15:35:00Z
Colorectal Cancer
The role of biomarker testing in cancer
Biomarkers can play important roles in cancer treatment, but what are they and what can they tell doctors?
2024-10-16T18:18:00Z
Hypertension
Home-based exercise tips for blood pressure control
Getting heart-healthy physical activity doesn't have to mean running a marathon or joining an expensive gym.
2024-09-08T18:30:00Z
Leukemia (AML)
What helps with nausea besides medicine?
Nausea is an unfortunate aspect of cancer treatment - what may help reduce this side effect?
2024-08-31T18:30:00Z
Obesity
A primer on GLP-1 receptor agonists for weight loss
An overview on select GLP-1 receptor agonist treatments that help promote blood sugar management and weight loss
2024-07-31T18:30:00Z